Skip to main content

Table 4 Correlation between ribavirin dose reduction or discontinuation and PCR for HCV week 24 (SVR rate)

From: Study the response of Qurevo (ombitasvir, paritaprevir, and ritonavir) in end-stage renal disease patients with hepatitis C virus

PCR for HCV, week 24

Ribavirin dose reduction or discontinuation

Chi-square

Yes

No

Total

N

%

N

%

N

%

X2

P-value

Positive

0

0.00

2

4.35

2

4.00

0.181

0.670

Negative

4

100.00

44

95.65

48

96.00

Total

4

100.00

46

100.00

50

100.00